Torres RH, González VC, Bieletto TO

Language: Spanish
References: 20
Page: 11-20
PDF size: 621.20 Kb.

ABSTRACT

The transrectal biopsy guided by ultrasound continues to be the method of choice for the accurate diagnosis of prostate cancer.
Objective. To know the relationship between weight of the prostate, levels of prostate specific antigen (PSA) and histopathological findings by age groups.
Material and method. A observational, transverse and descriptive study with a sample of 317 patients in a period of 10 years.
Results. Cancer incidence from 33.1% associated with an increase in the age, PSA level and value of Gleason. The total weight of the prostate and the transitional area from positive cancer patients was lower than in patients with negative biopsy. The acinar adenocarcinoma was the most common histological diagnosis and the average value of Gleason was 6. The surgical handling of inguinal duct and perianal region comprise 17% of the related background.
Conclusion. The partnership between age, APE and histopathology Gleason degree is remarkable. The total weight of the prostate and the transition zone were lower in positive patients to cancer and showed no association with age.

REFERENCES

1. Instituto Nacional de Geografía y Estadística. “Mujeres y Hombres en México” 2009. Decimotércera Edición. Ciudad de México: Instituto Nacional de las Mujeres, 2009; pp: 66.

2. Fütterer J, Heijmink S, Spermon JR. Imaging the male reproductive tract: current trends and future directions. Radiol Clin N Am 2008;46:133–147.

3. Hricak H, Choyke P, et al. Imaging Prostate Cancer. Radiology 2007;243:1.

4. Akin O, Hricak H. Imaging of prostate cancer. Radiol Clin N Am 2007;45:207–222.

5. PAC Urología-1 A3. Disponible en: http://www.drscope.com/pac/urologia/a3/a3_pag16.htm

6. Canto E, Shariat S, Slawin K. Biochemical staging of prostate cancer. Urol Clin N Am 2003;30:263–277.

7. Boyle P., Severi G, et al. The epidemiology of prostate cancer. Urol Clin N Am 2003;30:209–217.

8. Kessler B, Albersten P, et al. The natural history of prostate cáncer. Urol Clin N Am 2003;30:219–226.

9. Gleason DF, Mellinger G. The Veterans Administration Cooperative Urologic Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J Urol 1974;111:58–64.

10. Bostwick D, Qian J. Contemporary pathology of prostate cancer. Urol Clin N Am 2003;30:181–207.

11. Purohit R, Shinohara K. Imaging clinically localized prostate cancer. Urol Clin N Am 2003;30:279–293.

12. Hodge KK, McNeal JE et al. Ultrasound guided transrectal core biopsies of the palpably anormal prostate. J Urol 1989;142:66-70.

13. Hodge KK, McNeal JE et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-75.

14. Eskew LS, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosis of the prostate. J Urol 1997;157:199.

15. Babaian RJ, Toi A, Kamoi K et al. A comparative analysis of sextant and an extended 11 core multisistemic directed biopsy strategy. J Urol 2000;163:152.

16. Reyes Y, Castro M, Guerrero G. Eficacia de la biopsia transrectal guiada por ultrasonido con técnica extensa. An Radiol Mex 2009;8(2):177-181.

17. Lechuga A, Arenas J, Vega R. Cáncer de próstata diagnosticado por biopsia transrectal guiada por ultrasonido. Bol Coleg Mex Urol 2006;21(2):38-43.

18. Santiago J, Ayala F, Balcazar R. Frecuencia en el diagnóstico de cáncer de próstata a través de la toma de biopsia transrectal guiada por ultrasonido en el Hospital Regional Gral. I. Zaragoza, ISSSTE. An. Radiol Mex 2007;6(3):195-2000.

19. Fernández AJ, Andrade JD, Morales J et al. Aspectos epidemiológicos de las biopsias transrectales de próstata en el Hospital General Dr. Manuel Gea González. Rev Mex Urol 2008;68(5):257-261.

20. Wilson S, Crawford D. Screening for prostate cancer: current recommendations. Urol Clin N Am 2004;31:219–226.